Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In patients with eosinophilic gastritis or duodenitis, Lirentelimab reduced gastrointestinal eosinophils and symptoms. Infusion-related reactions were more common with Lirentelimab than with placebo
…